About
Erasca, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 27 2026
Erasca Announces Positive Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors
Mar 12 2026
Erasca Reports Fourth Quarter and Full Year 2025 Business Updates and Financial Results
Mar 10 2026
Erasca Exercises Option to Secure Worldwide Rights for ERAS-0015 Pan-RAS Molecular Glue to Include China, Hong Kong, and Macau
Mar 5 2026
Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat
Feb 24 2026
Erasca Announces Issuance of a U.S. Patent Covering Pan-KRAS Inhibitor ERAS-4001
Recent Videos

ERAS, Erasca, Inc., 2026-04-30, stock prices dynamics, stock of the day
May 01, 2026

RAS IP War: Revolution Medicines Just Dropped a Legal Bomb on Erasca.
Apr 30, 2026
![[미증시 속보] VISN, ERAS, RMBS, NVTS, CLS 5종목 주요 뉴스 & 급등락 정리 (2026년 4월 29일)](https://i.ytimg.com/vi/VPEB-yngbMg/hqdefault.jpg)
[미증시 속보] VISN, ERAS, RMBS, NVTS, CLS 5종목 주요 뉴스 & 급등락 정리 (2026년 4월 29일)
Apr 28, 2026

Market Open: Amazon Earnings Put AI Spending to the Test as Erasca Crashes on Trial News
Apr 28, 2026
Google Übersetzer